Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Townsend Richard Nolan sold 3,295 Lexeo Therapeutics, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 18, 2026

On Nov 17, 2026, Townsend Richard Nolan (Director, Chief Executive Officer) sold 3,295 Lexeo Therapeutics, Inc. shares at US$3.26 for US$10,742, leaving 373,483 shares. Filed Nov 18, 2026 (Form 4).

Sold
3,295 shares
Price
US$3.26
Value
US$10,742
Holding after
373,483 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockSale3,295US$3.26373,483Direct

Source

Download original · View original at SEC

Related